Date: August 15, 2019
GWEST Corporation Limited, for the three months ended June 30, 2019, booked Total Revenue amounting to $33.14 million, an increase of 30% when compared with the $25.41 million booked last year. Management noted, “this increase was positively influenced by a 52% increase in patient fees. Rental and lease income increased by 8% quarter over quarter”.
Cost of sales for the period amounted to $6.08 million relative to the $11.90 million reported for the same period last year. Consequently, gross profit increased 100% amounting to $27.06 million relative to the $13.50 million for the corresponding period in 2018.
Total expenses decreased 23% for the period to $36.08 million (2018: $46.76 million). Of this, Administrative expenses increased by 8% to close the period at $35.67 million (2018: $33.05 million) while Other operating expenses amounted to $406,000 down 97% from $13.71 million for the corresponding period in 2018.
Finance cost for the period amounted to $12.01 million relative to $8.36 million booked in for the comparable period in 2018. Management noted, “There was a $3.65 million increase in our finance cost and this was mainly attributed to our adoption of new International Financial Reporting Standards (IFRS 16).”
There was no taxation charges for the period, as such, Net Loss for the period amounted to $20.76 million relative to a Net Loss $41.62 million in 2018.
Loss per share (LPS) for the period amounted $0.043 compared to and loss per share of $0.086 recorded in 2018. The trailing-twelve-month LPS amounted to $0.237. The number of shares used in the calculations is 484,848,485. GWEST closed the trading period on August 14, 2019, at $1.16.
The Company noted, “The outlook for the future remains encouraging as we continue with our restructuring and rationalizing exercise while improving our revenue stream through increased marketing and forming alliances with our target customer base. Efforts to sell a portion of our investment properties and to negotiate financial arrangements to finance expansion plans with respect to our Surgery Centre and Inpatient Units are advancing as planned. Our open house held to showcase vacant spaces for lease and sale has yielded positive results which would translate to improved revenue in the near future. We will continue to analyse our offerings seek out opportunities for acquisitions where potential prospects may arise in the marketplace.”
Balance Sheet at a glance:
As at June 30, 2019, total assets amounted to $1.73 billion, 6% more than $1.63 billion the year prior. This was as a result of the increase in ‘Property and equipment’ which closed $511.52 million (2018: $392.71 million) however tempered by decreases in ‘Short term deposits’ which totalled $44.78 million ($129.90 million). The company stated that, “the primary contributing factor for the increase in total value of our balance sheet was due to the increase in our fixed and non-current assets mainly due to adoption of IFRS 16 which requires the recognition of long term leases as assets on our balance sheet.”
Shareholders’ Equity totalled $694.79 million (2018: $815.02 million) resulting in a book value per share of $1.43 (2018: $1.68).
Disclaimer: Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation (s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.
